Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot study. (Q45912924)
Jump to navigation
Jump to search
scientific article published on 11 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot study. |
scientific article published on 11 October 2012 |
Statements
1 reference
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis--a prospective, non-randomized pilot study. (English)
1 reference
N De Stefano
1 reference
E Portaccio
1 reference
M L Stromillo
1 reference
B Goretti
1 reference
B Hakiki
1 reference
A Giorgio
1 reference
F Rossi
1 reference
A De Leucio
1 reference
M P Amato
1 reference
11 October 2012
1 reference
20
1 reference
6
1 reference
986-990
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference